Organogenesis Holdings Inc (ORGO) — Capital Reinvestment Ratio
Latest as of September 2025:
0.73x
Organogenesis Holdings Inc (ORGO) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow ($3.08 Million) in capital expenditures ($2.23 Million). See how much free cash does Organogenesis Holdings Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.73x
Capex / Operating Cash Flow
Operating Cash Flow
$3.08 Million
USD
Capital Expenditures
$2.23 Million
USD
Data as of
Sep 2025
Most recent filing
Organogenesis Holdings Inc Capital Reinvestment Ratio (2020–2024)
This chart tracks Organogenesis Holdings Inc's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Organogenesis Holdings Inc (2020–2024)
Year-by-year Capital Reinvestment Ratio for Organogenesis Holdings Inc from 2020 to 2024. For live market cap and broader valuation context, see ORGO market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.71x | $14.21 Million | $10.03 Million | ▼ -10.4% |
| 2023 | 0.79x | $30.92 Million | $24.36 Million | ▼ -42.2% |
| 2022 | 1.36x | $24.86 Million | $33.90 Million | ▲ +170.7% |
| 2021 | 0.50x | $61.98 Million | $31.22 Million | ▼ -84.4% |
| 2020 | 3.23x | $5.47 Million | $17.68 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow